Ethanol-MDMA interactions in rats: The importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination

Psychopharmacology

Volumn 192, Issue 4, 2007, Pages 555-569

  Ben Hamida, Sami ^a   Plute, Erin ^a   Bach, Sonia ^a   Lazarus, Christine ^a   Tracqui, Antoine ^b   Kelche, Christian ^a   De Vasconcelos, Anne Pereira ^a   Jones, Byron C ^c   Cassel, Jean Christophe ^a  

^a Université de Strasbourg Faculté de Psychologie   (France)

^b INSTITUT DE MÉDECINE LÉGALE   (France)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Ecstasy; Ethanol; Locomotor activity; MDA; MDMA; Rat; Sensitization; Temperature; Tolerance

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; DOPAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ARTICLE; BEHAVIOR; BRAIN LEVEL; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL TEMPERATURE; HYPERTHERMIA; LOCOMOTION; MALE; MOTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; TREATMENT DURATION;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; BIOGENIC MONOAMINES; BODY TEMPERATURE; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG INTERACTIONS; DRUG TOLERANCE; ETHANOL; HALLUCINOGENS; MALE; MOTOR ACTIVITY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, LONG-EVANS;

EID: 34249863320     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-007-0752-9     Document Type: Article

References (90)

1. Ando RD, Benko A, Ferrington L, Kirilly E, Kelly PA, Bagdy G (2006) Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test. Neuropharmacology 50:884-896
2. Balogh B, Molnar E, Jakus R, Quate L, Olverman HJ, Kelly PA, Kantor S, Bagdy G (2004) Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology (Berl) 173:296-309
3. Bankson MG, Cunningham KA (2001) 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions. J Pharmacol Exp Ther 297:846-852
4. Barrett SP, Darredeau C, Pihl RO (2006) Patterns of simultaneous polysubstance use in drug using university students. Hum Psychopharmacol 21:255-263
5. Baumann MH, Wang X, Rothman RB (2007) 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology (Berl) 189(4):407-424
6. Ben Hamida S, Bach S, Plute E, Jones BC, Kelche C, Cassel JC (2006) Ethanol-ecstasy (MDMA) interactions in rats: preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment. Pharmacol Biochem Behav 84:162-168
7. Beveridge TJ, Mechan AO, Sprakes M, Pei Q, Zetterstrom TS, Green AR, Elliott JM (2004) Effect of 5-HT depletion by MDMA on hyperthermia and Arc mRNA induction in rat brain. Psychopharmacology (Berl) 173:346-352
8. Bexis S, Phillis BD, Ong J, White JM, Irvine RJ (2004) Baclofen prevents MDMA-induced rise in core body temperature in rats. Drug Alcohol Depend 74:89-96
9. Bishop C, Kamdar DP, Walker PD (2003) Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine- lesioned rats. Synapse 50:164-170
10. Broening HW, Bowyer JF, Slikker W Jr (1995) Age-dependent sensitivity of rats to the long-term effects of the serotonergic neurotoxicant (±)-3,4-methylenedioxymethamphetamine (MDMA) correlates with the magnitude of the MDMA-induced thermal response. J Pharmacol Exp Ther 275:325-333
11. Bull EJ, Porkess V, Rigby M, Hutson PH, Fone KC (2006) Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain. J Psychopharmacol 20:272-280
12. Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456-464
13. Cassel JC, Jeltsch H, Koenig J, Jones BC (2004) Locomotor and pyretic effects of MDMA-ethanol associations in rats. Alcohol 34:285-289
14. Cassel JC, Riegert C, Rutz S, Koenig J, Rothmaier K, Cosquer B, Lazarus C, Birthelmer A, Jeltsch H, Jones BC, Jackisch R (2005) Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. Neuropsychopharmacology 30:1870-1882
15. Chan AW, York JL (1994) Influence of age on the development of rapid tolerance to ethanol. Pharmacol Biochem Behav 47:567-573
16. Chu T, Kumagai Y, Distefano EW, Cho AK (1996) Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol 51:789-796
17. Colado MI, O'shea E, Granados R, Esteban B, Martin AB, Green AR (1999) Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration. Br J Pharmacol 126:911-924
18. Colboc O, Costentin J (1980) Evidence for thermoregulatory dopaminergic receptors located in the preopticus medialis nucleus of the rat hypothalamus. J Pharm Pharmacol 32:624-629
19. Corbett D, Evans S, Thomas C, Wang D, Jonas RA (1990) MK-801 reduced cerebral ischemic injury by inducing hypothermia. Brain Res 514:300-304
20. Dafters RI (1994) Effect of ambient temperature on hyperthermia and hyperkinesis induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') in rats. Psychopharmacology (Berl) 114:505-508
21. Dafters RI (1995) Hyperthermia following MDMA administration in rats: effects of ambient temperature, water consumption, and chronic dosing. Physiol Behav 58:877-882
22. Dafters RI, Lynch E (1998) Persistent loss of thermoregulation in the rat induced by 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') but not by fenfluramine. Psychopharmacology (Berl) 138:207-212
23. Daniel WA, Wojcikowski J, Palucha A (2001) Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br J Pharmacol 134:807-814
24. De La Garza R, Fabrizio KR, Gupta A (2007) Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology (Berl) 189:425-434
25. de la Torre R, Farre M (2004) Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 25:505-508
26. Easton N, Marsden CA (2006) Ecstasy: are animal data consistent between species and can they translate to humans? J Psychopharmacol 20:194-210
27. Fitzgerald RL, Blanke RV, Poklis A (1990) Stereoselective pharmacokinetics of 3,4-methylenedioxymethamphetamine in the rat. Chirality 2:241-248
28. Freedman RR, Johanson CE, Tancer ME (2005) Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 183:248-256
29. Gold LH, Koob GF (1989) MDMA produces stimulant-like conditioned locomotor activity. Psychopharmacology (Berl) 99:352-356
30. Gold LH, Hubner CB, Koob GF (1989) A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. Psychopharmacology (Berl) 99:40-47
31. Gough B, Ali SF, Slikker W Jr, Holson RR (1991) Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on monoamines in rat caudate. Pharmacol Biochem Behav 39:619-623
32. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508
33. Green AR, O'Shea E, Colado MI (2004a) A review of the mechanisms involved in the acute MDMA (ecstasy)-induced hyperthermic response. Eur J Pharmacol 500:3-13
34. Green AR, Sanchez V, O'Shea E, Saadat KS, Elliott JM, Colado MI (2004b) Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA. Psychopharmacology (Berl) 173:264-269
35. Green AR, O'Shea E, Saadat KS, Elliott JM, Colado MI (2005) Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146:306-312
36. Gudelsky GA, Koenig JI, Meltzer HY (1986) Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-HT1A receptors. Neuropharmacology 25:1307-1313
37. Hernandez-Lopez C, Farre M, Roset PN, Menoyo E, Pizarro N, Ortuno J, Torrens M, Cami J, de la Torre R (2002) 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300:236-244
38. Hetzler BE, Burkard HK (1999) Effects of dizocilpine (MK-801) on flash-evoked potentials, body temperature, and locomotor activity of hooded rats. Pharmacol Biochem Behav 62:559-573
39. Hopfer C, Mendelson B, Van Leeuwen JM, Kelly S, Hooks S (2006) Club drug use among youths in treatment for substance abuse. Am J Addict 15:94-99
40. Huttunen P, Lapinlampi T, Myers RD (1988) Temperature-related release of serotonin from unrestrained rats' pre-optic area perfused with ethanol. Alcohol 5:189-193
41. Iravani MM, Asari D, Patel J, Wieczorek WJ, Kruk ZL (2000) Direct effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin or dopamine release and uptake in the caudate putamen, nucleus accumbens, substantia nigra pars reticulata, and the dorsal raphe nucleus slices. Synapse 36:275-285
42. Ishiwata T, Saito T, Hasegawa H, Yazawa T, Otokawa M, Aihara Y (2004) Changes of body temperature and extracellular serotonin level in the preoptic area and anterior hypothalamus after thermal or serotonergic pharmacological stimulation of freely moving rats. Life Sci 75:2665-2675
43. Ishiwata T, Saito T, Hasegawa H, Yazawa T, Kotani Y, Otokawa M, Aihara Y (2005) Changes of body temperature and thermoregulatory responses of freely moving rats during GABAergic pharmacological stimulation to the preoptic area and anterior hypothalamus in several ambient temperatures. Brain Res 1048:32-40
44. Jaehne EJ, Salem A, Irvine RJ (2005) Effects of 3,4- methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation. Pharmacol Biochem Behav 81:485-496
45. Jansen KL (1999) Ecstasy (MDMA) dependence. Drug Alcohol Depend 53:121-124
46. Johnson EA, O'Callaghan JP, Miller DB (2004) Brain concentrations of d-MDMA are increased after stress. Psychopharmacology (Berl) 173:278-286
47. Jones DC, Lau SS, Monks TJ (2004) Thioether metabolites of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine inhibit human serotonin transporter (hSERT) function and simultaneously stimulate dopamine uptake into hSERT-expressing SK-N-MC cells. J Pharmacol Exp Ther 311:298-306
48. Kalivas PW (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37:95-100
49. Kalivas PW, Duffy P, White SR (1998) MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology 18:469-479
50. Khanna JM, Chau A, Shah G (1996) Characterization of the phenomenon of rapid tolerance to ethanol. Alcohol 13:621-628
51. Lee TF, Mora F, Myers RD (1985) Dopamine and thermoregulation: an evaluation with special reference to dopaminergic pathways. Neurosci Biobehav Rev 9:589-598
52. Liechti ME, Kunz I, Kupferschmidt H (2005) Acute medical problems due to ecstasy use. Case-series of emergency department visits. Swiss Med Wkly 135:652-657
53. Lin MT, Chandra A (1981) Blockade of nicotinic receptors in brain with d-tubocurarine induces decreased metabolism, cutaneous vasodilation and hypothermia in rats. Experientia 37:986-988
54. Lora-Tamayo C, Tena T, Rodriguez A, Moreno D, Sancho JR, Ensenat P, Muela F (2004) The designer drug situation in Ibiza. Forensic Sci Int 140:195-206
55. Malberg JE, Seiden LS (1998) Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18:5086-5094
56. Mallick BN, Jha SK, Islam F (2002) Presence of alpha-1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats. Neuropharmacology 42:697-705
57. Malpass A, White JM, Irvine RJ, Somogyi AA, Bochner F (1999) Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats. Pharmacol Biochem Behav 64:29-34
58. Marston HM, Reid ME, Lawrence JA, Olverman HJ, Butcher SP (1999) Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat. Psychopharmacology (Berl) 144:67-76
59. McGregor IS, Gurtman CG, Morley KC, Clemens KJ, Blokland A, Li KM, Cornish JL, Hunt GE (2003) Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. Psychopharmacology (Berl) 168:465-474
60. Mechan AO, O'Shea E, Elliott JM, Colado MI, Green AR (2001) A neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation. Psychopharmacology (Berl) 155:413-418
61. Mechan AO, Esteban B, O'Shea E, Elliott JM, Colado MI, Green AR (2002) The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats. Br J Pharmacol 135:170-180
62. Mills EM, Rusyniak DE, Sprague JE (2004) The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine. J Mol Med 82:787-799
63. Modi GM, Yang PB, Swann AC, Dafny N (2006) Chronic exposure to MDMA (ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants. Behav Brain Funct 2:1
64. Montiel-Duarte C, Varela-Rey M, Oses-Prieto JA, Lopez-Zabalza MJ, Beitia G, Cenarruzabeitia E, Iraburu MJ (2002) 3,4-Methylenedioxymethamphetamine ("ecstasy") induces apoptosis of cultured rat liver cells. Biochim Biophys Acta 1588:26-32
65. Myers RD (1981) Alcohol's effect on body temperature: hypothermia, hyperthermia or poikilothermia? Brain Res Bull 7:209-220
66. Nair SG, Gudelsky GA (2006) Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex. Brain Res Bull 69:382-387
67. Narahashi T, Aistrup GL, Marszalec W, Nagata K (1999) Neuronal nicotinic acetylcholine receptors: a new target site of ethanol. Neurochem Int 35:131-141
68. Oesterheld JR, Armstrong SC, Cozza KL (2004) Ecstasy: pharmacodynamic and pharmacokinetic interactions. Psychosomatics 45:84-87
69. O'Hearn E, Battaglia G, De Souza EB, Kuhar MJ, Molliver ME (1988) Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J Neurosci 8:2788-2803
70. O'Loinsigh ED, Boland G, Kelly JP, O'Boyle KM (2001) Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. Prog Neuropsychopharmacol Biol Psychiatry 25:621-638
71. O'Shea E, Granados R, Esteban B, Colado MI, Green AR (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37:919-926
72. O'shea E, Escobedo I, Orio L, Sanchez V, Navarro M, Green AR, Colado MI (2005) Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats. Neuropsychopharmacology 30:1312-1323
73. Parrott AC (2001) Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557-577
74. Parrott AC (2005) Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J Psychopharmacol 19:71-83
75. Piper BJ, Fraiman JB, Meyer JS (2005) Repeated MDMA ("ecstasy") exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. Dev Psychobiol 47:145-157
76. Piper BJ, Vu HL, Safain MG, Oliver AJ, Meyer JS (2006) Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist. J Pharmacol Exp Ther 317:838-849
77. Ramos M, Goni-Allo B, Aguirre N (2005) Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade. Neuropsychopharmacology 30:2180-2191
78. Saadat KS, O'Shea E, Colado MI, Elliott JM, Green AR (2005) The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature. Psychopharmacology (Berl) 179:884-890
79. Salomon L, Lanteri C, Glowinski J, Tassin JP (2006) Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci USA 103:7476-7481
80. Schifano F (2004) A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl) 173:242-248
81. Schifano F, Di Furia L, Forza G, Minicuci N, Bricolo R (1998) MDMA ('ecstasy') consumption in the context of polydrug abuse: a report on 150 patients. Drug Alcohol Depend 52:85-90
82. Schifano F, Oyefeso A, Webb L, Pollard M, Corkery J, Ghodse AH (2003) Review of deaths related to taking ecstasy, England and Wales, 1997-2000. BMJ 326:80-81
83. Scholey AB, Parrott AC, Buchanan T, Heffernan TM, Ling J, Rodgers J (2004) Increased intensity of ecstasy and polydrug usage in the more experienced recreational ecstasy/MDMA users: a WWW study. Addict Behav 29:743-752
84. Schwartz PJ, Wehr TA, Rosenthal NE, Bartko JJ, Oren DA, Luetke C, Murphy DL (1995) Serotonin and thermoregulation. Physiologic and pharmacologic aspects of control revealed by intravenous m-CPP in normal human subjects. Neuropsychopharmacology 13:105-115
85. Siliquini R, Faggiano F, Geninatti S, Versino E, Mitola B, Ippolito R (2001) Patterns of drug use among young men in Piedmont (Italy). Drug Alcohol Depend 64:329-335
86. Steketee JD (2005) Cortical mechanisms of cocaine sensitization. Crit Rev Neurobiol 17:69-86
87. Stephenson CP, Hunt GE, Topple AN, McGregor IS (1999) The distribution of 3,4-methylenedioxymethamphetamine "ecstasy"-induced c-fos expression in rat brain. Neuroscience 92:1011-1023
88. Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492
89. Wish ED, Fitzelle DB, O'Grady KE, Hsu MH, Arria AM (2006) Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health 55:99-104
90. Zeisberger E (1987) The roles of monoaminergic neurotransmitters in thermoregulation. Can J Physiol Pharmacol 65:1395-1401